ROCK SPRINGS CAPITAL
ROCK SPRINGS CAPITAL MANAGEMENT LP Legal Name
Adviser information for ROCK SPRINGS CAPITAL last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 18 |
---|---|
Investment Advisory/Research | 7 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 6 | $5.8B |
Non-Discretionary | 0 | $0 |
Total | 6 | $5.8B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 6 | $5.8B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 67 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
650 S. EXETER STREETSUITE 1070
BALTIMORE
MD
United States
Monday - Friday, 8:00 AM - 6:00 PM
Tel: 410-220-0130, Fax: 410-220-0144
Chief Compliance Officer
AIDAN O'CONNOR
GENERAL COUNSEL
650 S. EXETER STREET
SUITE 1070
BALTIMORE
MD
United States
Tel:
410-220-0130
Fax:
410-220-0144
A****@*********************M
(Full email address available in API data)
Regulatory Contact
MARK BUSSARD
MEMBER
650 S. EXETER STREET
SUITE 1070
BALTIMORE
MD
United States
Tel:
410-220-0130
Fax:
410-220-0144
M***@*********************M
(Full email address available in API data)
Industry Affiliates
FOUR PINES GENERAL PARTNER LLC | Other investment adviser, including financial plannersCommodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
ROCK SPRINGS GENERAL PARTNER LLC | Other investment adviser, including financial plannersCommodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
FOUR PINES MASTER FUND LP | Hedge Fund | $263.7M | $10.0M | 25 |
ROCK SPRINGS CAPITAL MASTER FUND LP | Hedge Fund | $5,505.0M | $10.0M | 635 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
ROCK SPRINGS CAPITAL LLC | Domestic Entity | – | GENERAL PARTNER | 03/2013 | < 5% |
BUSSARD, GORDON, MARGRAF ("MARK") | Individual | – | MEMBER/LIMITED PARTNER | 03/2013 | 25-50% |
MCPHAIL, GRAHAM, MORGAN | Individual | – | MEMBER/LIMITED PARTNER | 03/2013 | 25-50% |
JENNER, KRIS, HARLAN | Individual | – | MEMBER/LIMITED PARTNER | 03/2013 | 25-50% |
BUSSARD, GORDON, MARGRAF ("MARK") | Individual | ROCK SPRINGS CAPITAL LLC | MEMBER | 03/2013 | 25-50% |
MCPHAIL, GRAHAM, MORGAN | Individual | ROCK SPRINGS CAPITAL LLC | MEMBER | 03/2013 | 25-50% |
JENNER, KRIS, HARLAN | Individual | ROCK SPRINGS CAPITAL LLC | MEMBER | 03/2013 | 25-50% |
ETOH, NNAMDI, C | Individual | – | CHIEF FINANCIAL OFFICER | 01/2021 | < 5% |
O'CONNOR, AIDAN, HUGH | Individual | – | CHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL | 10/2022 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ACADIA HEALTHCARE COMPANY IN | COM | 80M | 1M | – |
ACCOLADE INC | COM | 8M | 2M | – |
ACLARIS THERAPEUTICS INC | COM | 3M | 3M | – |
ACUMEN PHARMACEUTICALS INC | COM | 6M | 2M | – |
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 2M | 2M | – |
AGILON HEALTH INC | COM | 58M | 9M | – |
AGIOS PHARMACEUTICALS INC | COM | 45M | 1M | – |
AKERO THERAPEUTICS INC | COM | 25M | 1M | – |
ALIGN TECHNOLOGY INC | COM | 31M | 128K | – |
ALLAKOS INC | COM | 1M | 1M | – |
ALNYLAM PHARMACEUTICALS INC | COM | 61M | 250K | – |
AMICUS THERAPEUTICS INC | COM | 12M | 1M | – |
APELLIS PHARMACEUTICALS INC | COM | 5M | 141K | – |
APPLIED THERAPEUTICS INC | COM | 7M | 2M | – |
ARGENX SE | SPONSORED ADR | 99M | 229K | – |
ASCENDIS PHARMA A/S | SPONSORED ADR | 40M | 290K | – |
AURINIA PHARMACEUTICALS INC | COM | 7M | 1M | – |
AUTOLUS THERAPEUTICS PLC | SPON ADS | 4M | 1M | – |
AZENTA INC | COM | 37M | 696K | – |
BEAM THERAPEUTICS INC | COM | 6M | 250K | – |
BIOCRYST PHARMACEUTICALS INC | COM | 22M | 4M | – |
BIOHAVEN LTD | COM | 4M | 128K | – |
BIOMARIN PHARMACEUTICAL INC | COM | 12M | 151K | – |
BIOMEA FUSION INC | COM | 815K | 181K | – |
BLUEPRINT MEDICINES CORP | COM | 265M | 2M | – |
BLUEPRINT MEDICINES CORP | COM | 6M | 57K | – |
BOSTON SCIENTIFIC CORP | COM | 63M | 818K | – |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 52M | 1M | – |
CHARLES RIV LABS INTL INC | COM | 12M | 60K | – |
COMPASS THERAPEUTICS INC | COM | 6M | 6M | – |
COMPUGEN LTD | ORD | 2M | 990K | – |
CRINETICS PHARMACEUTICALS IN | COM | 13M | 289K | – |
CULLINAN THERAPEUTICS INC | COM | 11M | 658K | – |
DEXCOM INC | COM | 57M | 500K | – |
DYNAVAX TECHNOLOGIES CORP | COM NEW | 15M | 1M | – |
DYNE THERAPEUTICS INC | COM | 16M | 461K | – |
EDAP TMS S A | SPONSORED ADR | 8M | 1M | – |
EDWARDS LIFESCIENCES CORP | COM | 51M | 550K | – |
ELI LILLY & CO | COM | 110M | 122K | – |
ENLIVEN THERAPEUTICS INC | COM | 10M | 429K | – |
ESSA PHARMA INC | COM NEW | 4M | 677K | – |
EVOLENT HEALTH INC | CL A | 78M | 4M | – |
EXACT SCIENCES CORP | COM | 46M | 1M | – |
FRESHPET INC | COM | 62M | 480K | – |
FULCRUM THERAPEUTICS INC | COM | 5M | 728K | – |
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 5M | – | – |
GOSSAMER BIO INC | COM | 3M | 3M | – |
HUMANA INC | COM | 55M | 147K | – |
IDEXX LABS INC | COM | 58M | 120K | – |
IMMUNOCORE HLDGS PLC | ADS | 14M | 419K | – |
IMMUNOVANT INC | COM | 31M | 1M | – |
INOZYME PHARMA INC | COM | 16M | 4M | – |
INSMED INC | COM PAR $.01 | 54M | 808K | – |
INSPIRE MED SYS INC | COM | 17M | 130K | – |
INSULET CORP | COM | 39M | 195K | – |
INTUITIVE SURGICAL INC | COM NEW | 133M | 299K | – |
IRHYTHM TECHNOLOGIES INC | COM | 43M | 398K | – |
JASPER THERAPEUTICS INC | COM NEW | 9M | 404K | – |
JOHNSON & JOHNSON | COM | 25M | 170K | – |
KORRO BIO INC | COM | 1M | 36K | – |
KRYSTAL BIOTECH INC | COM | 19M | 106K | – |
KYMERA THERAPEUTICS INC | COM | 35M | 1M | – |
KYVERNA THERAPEUTICS INC | COM | 1M | 179K | – |
LEAP THERAPEUTICS INC | COM NEW | 2M | 1M | – |
LEGEND BIOTECH CORP | SPONSORED ADS | 22M | 506K | – |
LIFESTANCE HEALTH GROUP INC | COM | 24M | 5M | – |
MACROGENICS INC | COM | 4M | 1M | – |
MADRIGAL PHARMACEUTICALS INC | COM | 69M | 245K | – |
MEREO BIOPHARMA GROUP PLC | SPON ADS | 33M | 9M | – |
MERSANA THERAPEUTICS INC | COM | 6M | 3M | – |
MERUS N V | COM | 59M | 1M | – |
MINERALYS THERAPEUTICS INC | COM | 4M | 379K | – |
MIRUM PHARMACEUTICALS INC | COM | 61M | 2M | – |
NEUMORA THERAPEUTICS INC. | COM | 7M | 760K | – |
NEUROCRINE BIOSCIENCES INC | COM | 129M | 940K | – |
NEVRO CORP | NOTE 2.750% 4/0 | 483K | – | – |
NEVRO CORP | COM | 12M | 1M | – |
NOVAVAX INC | COM NEW | 9M | 675K | – |
NOVO-NORDISK A S | ADR | 21M | 148K | – |
NUVALENT INC | COM | 19M | 256K | – |
NUVATION BIO INC | *W EXP 07/07/202 | 21K | 134K | – |
OLINK HLDG AB | SPONSORED ADS | 13M | 500K | – |
OSCAR HEALTH INC | CL A | 20M | 1M | – |
PACIRA BIOSCIENCES INC | COM | 22M | 785K | – |
PENUMBRA INC | COM | 48M | 265K | – |
PERSPECTIVE THERAPEUTICS INC | COM NEW | 4M | 401K | – |
PHARVARIS N V | COM | 14M | 757K | – |
PHREESIA INC | COM | 51M | 2M | – |
PLIANT THERAPEUTICS INC | COM | 4M | 385K | – |
PROTHENA CORP PLC | SHS | 13M | 625K | – |
PULMONX CORP | COM | 4M | 652K | – |
REVOLUTION MEDICINES INC | COM | 37M | 943K | – |
RHYTHM PHARMACEUTICALS INC | COM | 53M | 1M | – |
SAGIMET BIOSCIENCES INC | COM SER A | 3M | 788K | – |
SAREPTA THERAPEUTICS INC | COM | 45M | 284K | – |
SPRINGWORKS THERAPEUTICS INC | COM | 8M | 200K | – |
SPRUCE BIOSCIENCES INC | COM | 1M | 3M | – |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 3M | 66K | – |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 39M | 1000K | – |
TALPHERA INC | COM NEW | 282K | 316K | – |
TRAVERE THERAPEUTICS INC | COM | 37M | 4M | – |
TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 3M | – | – |
ULTRAGENYX PHARMACEUTICAL IN | COM | 79M | 2M | – |
UNITEDHEALTH GROUP INC | COM | 140M | 275K | – |
VERA THERAPEUTICS INC | CL A | 14M | 381K | – |
VIGIL NEUROSCIENCE INC | COM | 2M | 472K | – |
VINCERX PHARMA INC | COM NEW | 722K | 892K | – |
WARBY PARKER INC | CL A COM | 33M | 2M | – |
WEST PHARMACEUTICAL SVSC INC | COM | 48M | 146K | – |
XENON PHARMACEUTICALS INC | COM | 50M | 1M | – |
XILIO THERAPEUTICS INC | COM | 3M | 3M | – |
ZAI LAB LTD | ADR | 22M | 1M | – |